Fast Five Quiz: Type 2 Diabetes Mellitus Comorbidities

Romesh Khardori, MD, PhD

Disclosures

January 30, 2020

High LDL-C and TG levels and low HDL-C levels is the most prevalent pattern of dyslipidemia in patients with type 2 DM. Regarding the treatment of dyslipidemia, statin therapy remains the recommended initial treatment for dyslipidemia based on trials showing the effectiveness in these drugs as primary and secondary preventive agents for coronary heart disease.

Patients with type 2 DM who have coexisting CVD and LDL-C levels ≥ 70 mg/dL (receiving a maximally tolerated statin dose) may further benefit from the addition of ezetimibe or a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.

For patients with type 2 DM and hypertension, the third-generation beta-blocker carvedilol may be effective in managing dyslipidemia. Patients with type 2 DM already taking renin-angiotensin blockers who were prescribed carvedilol had significant decreases in TG, total cholesterol, and non–HDL-C levels.

Learn more about managing dyslipidemia in patients with type 2 DM.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....